drugset / Trial / NCT05382806
Reversal of Remimazolam by a Single Dose of Flumazenil
RandomizedParallel-groupDouble-blindTreatment
Summary
Remimazolam, a brand-new sedative which has benzodiazepine property. It is an ultra-short acting sedative and regarded as a proper drug for procedural sedation.
Timeline
- Start
- 2022-08-02
- Primary completion
- 2023-05-10
- Completion
- 2023-05-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Flumazenil | Small molecule | 0.2 mg | — |
Indications
No indication recorded.